Takara Holdings Inc
TSE:2531
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (8.5), the stock would be worth ¥834.65 (53% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 18.2 | ¥1 780 |
0%
|
| 3-Year Average | 8.5 | ¥834.65 |
-53%
|
| 5-Year Average | 6.9 | ¥679.44 |
-62%
|
| Industry Average | 14.1 | ¥1 378.38 |
-23%
|
| Country Average | 13.6 | ¥1 335.78 |
-25%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Takara Holdings Inc
TSE:2531
|
343.3B JPY | 18.2 | 25 | |
| CN |
|
Kweichow Moutai Co Ltd
SSE:600519
|
1.8T CNY | 14.9 | 21.5 | |
| CN |
|
Wuliangye Yibin Co Ltd
SZSE:000858
|
392.7B CNY | 7.1 | 14 | |
| UK |
|
Diageo PLC
LSE:DGE
|
32.7B GBP | 11.7 | 13.5 | |
| ZA |
D
|
Distell Group Holdings Ltd
JSE:DGH
|
40.2B ZAR | 11.6 | 16.9 | |
| US |
|
Constellation Brands Inc
NYSE:STZ
|
27B USD | 12.4 | 16 | |
| CN |
|
Shanxi Xinghuacun Fen Wine Factory Co Ltd
SSE:600809
|
173.7B CNY | 9.9 | 14.2 | |
| CN |
|
Luzhou Laojiao Co Ltd
SZSE:000568
|
149.9B CNY | 7.3 | 11.9 | |
| FR |
|
Pernod Ricard SA
PAR:RI
|
16.5B EUR | 10.2 | 11.7 | |
| US |
|
Brown-Forman Corp
NYSE:BF.B
|
13B USD | 12.7 | 10.2 | |
| CN |
|
Jiangsu Yanghe Brewery Joint-Stock Co Ltd
SZSE:002304
|
75.4B CNY | 17.4 | 36.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 9.8 |
| Median | 13.6 |
| 70th Percentile | 18.1 |
| Max | 414 821 439 |
Other Multiples
Takara Holdings Inc
Glance View
Takara Holdings Inc. is a fascinating example of a modern company deeply rooted in tradition yet dynamically evolving in the contemporary marketplace. Originating in Japan, Takara Holdings has its historical roots in the production of sake, a cornerstone of Japanese culture. Over time, the company has skillfully expanded its horizons, becoming a diversified entity that intricately blends the old with the new. The spirits division continues to honor its origins by producing high-quality sake and shochu, products that hold significant cultural value in Japan and are increasingly appreciated in global markets. This traditional beverage production remains a pivotal part of Takara's revenue stream. Complementing its robust alcohol business, Takara has strategically diversified into biotechnology and food businesses. Through its bio-tech ventures, Takara is involved in the development and sale of biomedical products such as reagents, contributing to scientific research and healthcare industries worldwide. This diversification not only supplements its financial health but also positions the company as a player in the burgeoning health and wellness sectors. Meanwhile, Takara's food division explores culinary innovation, catering to evolving consumer tastes and dietary trends. This blend of traditional and innovative products demonstrates Takara Holdings' ability to honor its rich heritage while simultaneously embracing forward-looking growth opportunities to drive revenue.